TY  - JOUR
AU  - Trujillo-Santos, J
AU  - Bergmann, J F
AU  - Bortoluzzi, C
AU  - López-Reyes, R
AU  - Giorgi-Pierfranceschi, M
AU  - López-Sáez, J B
AU  - Ferrazzi, P
AU  - Bascuñana, J
AU  - Suriñach, J M
AU  - Monreal, M
PY  - 2017
DO  - 10.1111/jth.13616
UR  - http://hdl.handle.net/10668/10804
T2  - Journal of thrombosis and haemostasis : JTH
AB  - Essentials In venous thromboembolism (VTE), it is uncertain if enoxaparin should be given twice or once daily. We compared the 15- and 30-day outcomes in VTE patients on enoxaparin twice vs. once daily. Patients on enoxaparin once daily had fewer...
LA  - en
KW  - bleeding
KW  - enoxaparin
KW  - mortality
KW  - recurrences
KW  - regimen
KW  - venous thromboembolism
KW  - Acute Disease
KW  - Aged
KW  - Anticoagulants
KW  - Drug Administration Schedule
KW  - Enoxaparin
KW  - Europe
KW  - Female
KW  - Hemorrhage
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Registries
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Treatment Outcome
KW  - Venous Thromboembolism
KW  - Venous Thrombosis
TI  - Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism.
TY  - research article
VL  - 15
ER  -